Funder: Roche
Due Dates: August 20, 2024 (Multiple Sclerosis RFP) | May 15, 2026 (Diffuse Large B-Cell Lymphoma RFP)
Funding Amounts: Up to $500,000 (Multiple Sclerosis) | Up to $150,000 (Diffuse Large B-Cell Lymphoma); typically for one-year projects.
Summary: Supports independent, accredited medical education initiatives to advance healthcare professional knowledge and improve patient outcomes in prioritized disease areas.
Key Information: Strict independence and firewall policies; U.S.-based accredited providers only; disease focus varies by RFP.